Subscribe to Newsletter

May 2019 Issue of The Medicine Maker

Welcome to the May issue! Medical cannabis and scientific research around cannabinoids is booming, but what does this mean for the pharma industry? Read our feature to find out. Meanwhile, Upfront explores the bioactivity of Actinobacteria found within brown seaweed, and how will the industry shape up over the next five years with an infographic. Heather Zenk argues that blockchain could be one solution to the saleable returns verification aspect of the US Drug Supply Chain Security Act, in In My View; and we tell the story of IPEC's humble beginnings with David Schoneker in Best Practice. Finally, we Sit Down With Robert S. Langer, Pediatrics Polymath, Jinling Chen.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Manufacture Small Molecules

Small, But Never Forgotten

| Stephanie Vine

A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.

Discovery & Development Drug Discovery

Solutions In... Nanoparticles

| Maryam Mahdi

Why are spherical nucleic acids so exciting for drug development?

Business & Regulation Trends & Forecasts

2023: Prices and Predictions

| Maryam Mahdi

How will the industry shape up over the next five years?

Discovery & Development Drug Discovery

Treasures of the Deep

| Maryam Mahdi

Could aquatic bacteria hold the keys to bolstering our drug pipelines?

Business & Regulation Biosimilars

Business in Brief

| Stephanie Vine

The latest business news and views in pharma.

Business & Regulation Contract Manufacturing Services

(Block)chain Reaction

| Heather Zenk

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.

Discovery & Development Drug Discovery

The Killer Combo

| Anthony Coates

Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?

Discovery & Development Formulation

Choosing the Right Excipients for the Right Job

| Rob Harris

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Manufacture Trends & Forecasts

Under Construction: Pharma's Cannabinoid Bid

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Manufacture Bioprocessing - Upstream & Downstream

Built on Innovation

| Sponsored by Schott

Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients.

Business & Regulation Standards & Regulation

The IPEC Story: Promoting Ingredients for Success

| With David Schoneker

High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry.

Manufacture Contract Manufacturing Services

Perks and Pitfalls of Antibody Drug Conjugates

| Stephanie Vine

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

Discovery & Development Drug Discovery

Bright SPARK

| Maryam Mahdi

Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.

Business & Regulation Formulation

Pediatrics Polymath

| Jinling Chen

Sitting Down With… Jinling Chen, Vice President, Pharmaceutical Development Services, WuXi STA, China.

Other issues of 2019